Abstract
The immune response is strictly and continuously regulated by a highly complex network of soluble mediators (i.e., cytokines and growth factors) that usually act as autocrine and/or paracrine regulators of cell growth and function. Under pathological conditions, however, when these mediators are produced in larger amounts in tissues or by circulating cells, they can be detected in biological fluids, and may exert hormone-like effects. Thus, the analysis of body fluids (such as serum, cerebrospinal fluid, urine and synovial fluid) for the presence of cytokines may constitute a strategy to define the role of these factors in inflammatory reactions in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abbott, R.J., Bolderson, I., Gruer, P.J.K., and Peatfield, R.C., 1987. Immunoreactive IFN-7 in CSF in neurological disorders. J. Neurol.Neurosurg.Psychiat. 50: 882.
Adachi, A., Kumamoto., R., and Araki, S., 1989. Interleukin 2 receptor levels indicating relapse in multiple sclerosis. Lancet i: 559.
Adachi, A., Kumamoto, R., and Arachi, S., 1990. Elevated soluble interleukin-2 receptor levels in patients with multiple sclerosis. Ann.Neurol 28: 687.
Baron, J.L., Madri, J.A., Ruddle, N.H., Hashim, G., Janeway, C.A. Jr., 1993. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp.Med. 177: 57.
Benveniste, E.N., Sparacio, S.M., Norris, J.G., Grenett, H.E., and Fuller, G.M., 1990. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30: 201.
Bernard, J.T., Ameriso, S., Kempf, R.A., Rosen, P., Mitchell, M.S., Fisher, M., 1990. Transient focal neurologic deficits complicating interleukin-2 therapy. Neurology 40: 154.
Brosnan, C.F., Selmaj, K.W., Raine, C.S., 1988. Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J. Neuroimmunol 18: 87.
Cotran, R.S., Pober, J.S., Gimbrone, M.A., Springer, T.A. Jr., Wiebke, E.A., Gaspari, A.A., Rosemberg, S.A., and Lotze, M.T., 1987. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. J. Immunol 139: 1883.
Deckert-Schlüter, M., Schlüter, D., and Schwendemann, G., 1992. Evaluation of IL-2, SIL-2R, IL-6, TNFα, and IL-1ßlevels in serum and CSF of patients with optic neuritis. J. NeurolSci. 113: 50.
de Maeyer, E., and de Maeyer-Guignard, J., 1991. Interferons, in: “The Cytokine Handbook”, A. Thomson, ed., Academic Press Ltd., London.
Denicoff, K.D., Rubinoff, D.R., and Papa, M.Z., 1987. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann. lntern. Med. 107: 293.
Dinarello, C.A., 1987. Interleukins, tumor necrosis factors (cachectin), and interferons as endogenous pyrogens and mediators of fever. Limphokines 14: 1.
Dinarello, C.A., 1989. Interleukin-1 and its biologically related cytokines, Adv.Immunol. 44: 153.
Dinarello, C.A., 1991. Interleukin-1, in: “The Cytokine Handbook”, A. Thomson, ed., Academic Press Ltd, London.
Dinarello, C.A., and Wolff S.M., 1993. The role of interleukin-1 in disease, N. Engl.Med. 328: 106.
Ellison, M.D., Krieg, R.J., Povlishock, J.T., 1990. Differential central nervous system responses following single and multiple recombinant interleukin-2 infusions. J. Neuroimmunol 28: 249.
Ellison, M.D., and Merchant, R.E., 1991. Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats. J. Neuroimmunol. 33: 245.
Fontana, A., Fierz, W., and Wekerle, H., 1984. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307: 273.
Franciotta, D.M., Grimaldi, L.M.E., Martino, G.V., Piccolo, G., Bergamaschi, R., Citterio, A., and Melzi d’Eril, G.V., 1989. Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis. Ann.Neurol 26: 787.
Frei, K., Siepl, C., Groscurth, P., Bodmer, S., Schwerdel., C., and Fontana, A., 1987. Antigen presentation and tumor cytotoxicity by interferon-gamma treated microglial cells. Eur.J. Immunol. 17: 1271.
Frei, K., Leist, T.P., Meager, A., Gallo, P., Leppert, D., Zinkemagel, R.M., and Fontana, A., 1988. Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J. Exp.Med. 168: 449.
Frei, K., Malipiero, U.V., Leist, T.P., Zinkemagel, R.M., Schwab, M.E., and Fontana, A., 1989. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. lmmunol 19: 689.
Gallo, P., Piccinno, M.G., Pagni, S., and Tavolato, B., 1988. Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients. Ann.Neuro/l 24: 795.
Gallo, P., Argentiero, V., Piccinno, M.G., Giometto, B., Pagni, S., Bozza, F., and Tavolato, B., 1989a. Soluble mediators of the immune response in cerebrospinal fluid and serum of patients with multiple sclerosis, in: “Multiple Sclerosis Research”, M.A. Battaglia, ed., Elsevier Science Publisher B.V. (Biomedicai Division), Amsterdam.
Gallo, P., Frei, K., Rordorf, C., Lazdins, J., Tavolato, B., and Fontana, A., 1989b. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23: 109.
Gallo, P., Piccinno, M.G., Pagni, S., Argentiero, V., Giometto, B., Bozza, F., and Tavolato, B., 1989c. Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and IFN gamma levels in serum and cerebrospinal fluid. J. Neurol.Sci. 92: 9.
Gallo, P., Piccinno, M.G., Krzalic, L., and Tavolato, B., 1989d. Tumor necrosis factor alpha (TNFα) and neurological diseases. Failure in detecting TNFαin the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumors. J. Neuroimmunol. 23: 41.
Gallo, P., Frei, K., Leppert, D., and Fontana, A., 1990. On the intrathecal synthesis of immunoglobulins: detection of BSF-2/IL-6 in CSF, in: “Trends in Neuroimmunology”, M.G. Marrosu, C. Cianchetti, and B. Tavolato, eds., Plenum Press, New York.
Gallo, P., Giometto, B., and Tavolato, B., 1991a. Neuroimmunology of HIV-1 infection. Arch. AIDS Res. 5: 53.
Gallo. P., Laverda, A.M., De Rossi, A., Pagni, S., Del Mistro, A., Cogo, P., Piccinno M.G., Plebani, A., Tavolato, B., and Chieco-Bianchi, L., 1991b. Immunological markers in the cerebrospinal fluid of HIV-1-infected children. Acta Paediatr.Scand. 80: 659.
Gallo, P., Piccinno, M.G., Tavolato, B., and Siden, A., 1991c. A longitudinal study on IL-2, sIL-2R, IL-4, and IFN gamma in multiple sclerosis CSF and serum. J. Neurol.Sci. 101: 227.
Gorczynski, M., and Keystone, E.J., 1986. Interleukin-1 activity in human cerebrospinal fluid, Immunol.Lett. 13: 231.
Greenberg, S.J., Marcon, L., Hurwitz, B.J., Waldmann, T.A., Nelson, D.L., 1988. Elevated levels of soluble interleukin-2 receptors in multiple sclerosis. N. Engl.Med. 319: 1019.
Grimaldi, L.M.E., Marino, G.V., Franciotta, D.M., Brustia, R., Castagna, A., Pristerà, R., and Lazzarin, A., 1991. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann.Neurol. 29: 21.
Hartung, H.-P., Hughes, R.A.C., Taylor, W.A., Heininger, K., Reiners, K., and Toyka, K.V., 1990. T cell activation in Guillain-BarréSyndrome and in MS: elevated serum levels of soluble IL-2 receptors. Neurology 40: 215.
Hauser, S.L., Doolittle, T.H., Lincoln, R., Brown, R.H., and Dinarello, CA., 1990. Cytokine accumulation in CSF of multiple sclerosis: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40: 1735.
Helfgott, D.C., Tatter, S.B., Santhanam, U., Clarick, R.H., Bhardway, N., May, L.T., and Sehgal, P.B., 1989. Multiple forms of IFN-ß2/IL-6 in serum and body fluids during acute bacterial infection. J. Immunol. 142: 948.
Hirsh, R.L., Panitch, H.S., and Johnson, K.P., 1985. Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro. J. Clin.Immunol. 5: 386.
Houssiau, F.A., Bukasa, K., Sindic, C.J.M., Van Damme, J.V., and Van Snick, J., 1988. Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin.Exp-Immunol.71: 320.
Helle, M., Boeije, L., de Groot E., de Vos, A., and Aarden, L.A., 1991. Sensitive ELISA for interleukin-6.Detection of IL-6 in biological fluids: synovial fluids and sera. J. Immunol.Meth. 138: 47.
Hirano, T., 1991. Interleukin-6, in: “The Cytokine Handbook”, A. Thomson, ed., Academic Press, London.
Kittur, S.D., Kittur, D.S., Soncrant, T.T., Rapoport, S.I., Tourtellotte, W.W., Nagel, J.E., and Adler, W.H., 1990. Soluble interleukin-2 receptors in the cerebrospinal fluid from individuals with various neurological disorders. Ann.Neurol. 28: 168.
Lebon, P., Schuller, E., Degos, J.-D., Lyon-Caen, O., and Ponsot, G., 1987. CSF alpha and gamma interferons in acute and subacute encephalitis and in multiple sclerosis: comparative study, in: “Cellular and Humoral Immunological Components of Cerebrospinal Huid in Multiple Sclerosis”, A. Lowenthal and J. Raus, eds., Plenum Press, New York.
Lebon, P., Boutin, B., Dulac, O., Ponsot, G., and Arthuis, M., 1988. Interferon in acute and subacute encephalitis. Br.Med.J. 296: 9.
Leist, T.P., Frei, K., Kam-Hansen, S., Zinkernagel, R.M., and Fontana, A., 1988. Tumor necrosis factor a in cerebrospinal fluid during bacterial, but not viral meningitis. Evaluation in murine model infections and in patients. J. Exp. Med. 167: 1743.
Leppert, D., Frei, K., Gallo, P., Yasargil, M.G., Hess, K., Baumgartner, G., and Fontana, A., 1989. Brain tumor: detection of B-cell stimulatory factor-2/interleukin-6 in the absence of oligoclonal bands of immunoglobulins. J. Neuroimmunol. 24: 259.
Maimone, D., Gragory, S., Arnason, B.G.W., and Reder, A., 1991. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J. Neuroimmunol. 32: 67.
Manogue, K.R., van Deventer, S.J.H., and Cerami, A., 1991. Tumor necrosis factor alpha or cachectin, in: “The Cytokine Handbook”, A. Thomson, ed., Academic Press, London.
Mantovani, A., and Dejana, E., 1989. Cytokines as communication signals between leukocytes and endothelial cells. Immunol.Today 10: 370.
McClain, J., Cohen, D., Ott, L., Dinarello, CA., and Young, B., 1987. Ventricular fluid interleukin-1 activity in patients with head injury, J. Lab.Clin.Med. 110: 48.
McCracken, G.H. Jr., Mustafa, M.M., Ramilo, O., Olsen, K.D., and Risser, R.C., 1989. Cerebrospinal fluid interleukin-1ßand tumor necrosis factor concentrations and outcome from neonatal gram-negative enteric bacillary meningitis. Pediatr.Infect.Dis.J. 8: 155.
Mustafa, M.M., Lebel, M.H., Ramilo O., Olsen, K.D., Resch, J.S., Beutler, B., and McCracken, G.H. Jr., 1989a. Correlation of interleukin-1ßand cachectin concentration in cerebrospinal fluid and outcome from bacterial meningitis. J. Paediatr. 115: 208.
Mustafa, M.M., Ramilo, O., Olsen, K.D., Franklin, P.S., Hansen, E.J., Beutler, B., and McCracken, G.H., 1989b. Tumor necrosis factor in mediating experimental Haemophilus Influenzae type b meningitis. J. Clin.Jnvest. 84: 1253.
Nadal, D., Leppert, D., Frei, K., Gallo, P., Lamche, H., and Fontana, A., 1989. Tumor necrosis factor-αin infectious meningitis. Arch.Dis.Child. 64: 1274.
Nijsten, M.W.N., de Groot, E.R., ten Duis, HJ., Klasen, HJ., Hack, CE., and Aarden, L.A., 1987. Serum levels of interleukin-6 and acute phase responses. Lancet ii: 921.
Peter, J.B., Boctor, F.N., Tourtellotte, W.W., 1991. Serum and CSF levels of IL-2, sIL-2R, TNFa, and IL-lßin chronic progressive multiple sclerosis: expected lack of clinical utility. Neurology 41: 121.
Quagliarello, V.J., Wispelwey, B., Long, W.J., and Scheid, W.M., 1991. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat: characterization and comparison with tumor necrosis factor. J. Clin.Invest. 87: 1360.
Quagliarello, V.J., and Scheid, W.M., 1992. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N. Engl.Med. 327: 864.
Ramilo, O., Mustafa, M.M., Sáez-Llorens, X., Mertsola, J., Ohkawara, S., Yoshinaga, M., Hansen, EJ., and McCracken, G.H. Jr., 1989. Role of interleukin 1-beta in meningeal inflammation. Ped.Infect.Dis.J. 12: 909.
Ramilo, O., Sáez-Llorens, X., Mertsola, J., Jafari, H., Olsen, K.D., Hansen, E.J., Yoshinaga, M., Ohkawara, S., Nariuchi, H., and McCracken, G.H. Jr., 1990. Tumor necrosis factor a/cachectin and interleukin 1ßinitiate meningeal inflammation. J. Exp.Med. 172: 497.
Robbins, D.S., Shirazi, Y., Drysdale, B.-E., Lieberman, A., Shin, H.S., and Shin, M.L., 1987. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol. 139: 2597.
Saukkonen, K., Sande, S., Cioffe, C., Wolpe, S., Sherry, B., Cerami, A., and Tuomanen, E., 1990. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J. Exp. Med. 171: 439.
Selmaj, K.W., and Raine, C.S., 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitto. Ann.Neurol. 23: 339.
Sharief, M.K., Hentges, R., and Thompson, EJ., 1991a. The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis. J. Neuroimmunol. 32: 43.
Sharief, M.K., Phil, M., and Hentges, R., 1991b. Association between tumor necrosis factor-a and disease progression in patients with multiple sclerosis. N. Engi.Med. 325: 467.
Shaskan, E.G., Thompson, R.M., and Price, R.W., 1992. Undetectable tumor nercrosis factor-alpha in spinal fluid from HIV-1-infected patients. Ann.Neurol. 31: 687.
Symons, A., Bundick, R.V., Suckling, A.J., and Rumsby, M.G., 1987. Cerebrospinal fluid interleukin-1-like activity during chronic relapsing experimental allergic encephalomyelitis. Clin.Exp.Immunol. 68: 648.
Tsukada, N., Miyagi, K., Matsuda, M., Yanagisawa, N., and Kone, K., 1991. Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J. Neurol. Sci. 102: 230.
Van Meir, E., Sawamura, Y., Diserens, A.-C., Hamou, M.F., and de Tribolet, N., 1990. Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res. 50: 6683.
Van Oers, M.H.J., Van der Heyden, A.A.P.A.M., and Aarden, L.A., 1988. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin.Exp.Immunol. 71: 314.
Vecht, C.J., Keohane, C., Menon, R.S., Henzen-Logmans, S.C., Punt., C.J.A., Stoter, G., 1990. Acute fatal leukoencephalopathy after interleukin-2 therapy. N. Engl.Med. 323: 1146.
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., and Espevik, T., 1989a. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp.Med. 169: 333.
Waage, A., Halstensen, A., Shalaby, R., Brandtzaeg, Kierulf, P., and Espevik, T., 1989b. Local production of tumor necrosis factor a, interleukin 1ß, and interleukin 6 in meningococcal meningitis. J. Exp.Med. 170: 1859.
Weiler, M., Stevens, A., Sommer, N., Melms, A., Dichgans, J., and Wiethölter, H., 1991. Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders. J. Neurol. Sci. 104: 215.
Wesselingn, S.L., Gough, N.M., Finlay-Jones, J.J., and McDonald, P.J., 1990. Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction. Lymphok.Res. 9: 177.
Yasukawa, K., Hirano, T., Watanabe, Y., Muratani, K., Matsuda, K., Nakai, S., and Kishimoto, T., 1987. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J. 6: 2939.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tavolato, B., Gallo, P. (1994). Intrathecal Cytokine Synthesis in Inflammatory and Demyelinating Diseases of the Central Nervous System. In: Salvati, S. (eds) A Multidisciplinary Approach to Myelin Diseases II. NATO ASI Series, vol 258. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2435-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2435-9_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6034-6
Online ISBN: 978-1-4615-2435-9
eBook Packages: Springer Book Archive